OGIAX
Price
$15.55
Change
+$0.07 (+0.45%)
Updated
Apr 25 closing price
Net Assets
5.32B
RLBAX
Price
$33.49
Change
+$0.12 (+0.36%)
Updated
Apr 25 closing price
Net Assets
230.79B
Ad is loading...

OGIAX vs RLBAX

Header iconOGIAX vs RLBAX Comparison
Open Charts OGIAX vs RLBAXBanner chart's image
JPMorgan Investor Balanced A
Price$15.55
Change+$0.07 (+0.45%)
VolumeN/A
Net Assets5.32B
American Funds American Balanced R1
Price$33.49
Change+$0.12 (+0.36%)
VolumeN/A
Net Assets230.79B
OGIAX vs RLBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OGIAX vs. RLBAX commentary
Apr 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGIAX is a Hold and RLBAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 231B vs. OGIAX (5.32B). OGIAX pays higher dividends than RLBAX: OGIAX (2.97) vs RLBAX (1.27). OGIAX was incepted earlier than RLBAX: OGIAX (28 years) vs RLBAX (23 years). RLBAX (1.33) is less costly to investors than OGIAX (0.96). RLBAX is a more actively managed with annual turnover of: 171.00 vs. OGIAX (7.00). RLBAX has a lower initial minimum investment than OGIAX: RLBAX (250) vs OGIAX (500). OGIAX annual gain was more profitable for investors over the last year : 5.13 vs. RLBAX (4.06). RLBAX return over 5 years is better than : 32.01 vs. OGIAX (26.21).
OGIAXRLBAXOGIAX / RLBAX
Total Expense Ratio0.961.3372%
Annual Report Gross Expense Ratio0.961.3372%
Fund Existence28 years23 years-
Gain YTD-0.354-1.40625%
Front Load5%N/A-
Min. Initial Investment500250200%
Min. Initial Investment IRAN/AN/A-
Net Assets5.32B231B2%
Annual Yield % from dividends2.971.27233%
Returns for 1 year5.134.06126%
Returns for 3 years8.8414.3662%
Returns for 5 years26.2132.0182%
Returns for 10 years22.7541.4355%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX106.730.97
+0.92%
Neurocrine Biosciences
EVO4.220.01
+0.24%
Evotec SE
SIBN14.410.02
+0.14%
SI-BONE
CNF0.66N/A
+0.02%
CNFinance Holdings Limited
SBFM1.51-0.04
-2.58%
Sunshine Biopharma Inc